Manufacturing and Delivery Sample Clauses

Manufacturing and Delivery. During the Term, and subject to the provisions of this Section 7, AeroGen shall manufacture for and supply to PathoGenesis, and PathoGenesis shall purchase from AeroGen, all of the requirements of PathoGenesis, its Affiliates and sublicensees for the Inhalers and Adapters (excluding the Ampoules) in the Territory. AeroGen shall manufacture the Inhaler: (i) in compliance with cGMP; (ii) in compliance with all regulatory requirements imposed by FDA; and (iii) in accordance with AeroGen's internal quality control standards and product specifications or as otherwise agreed upon by AeroGen and PathoGenesis. To enable AeroGen to comply with its obligations with respect to regulatory requirements outside the United States, PathoGenesis shall inform AeroGen as early as practical of its intention to pursue regulatory approval of the Product in a country outside the United States. Upon AeroGen's reasonable request, PathoGenesis and AeroGen shall meet and confer regarding the regulatory requirements of such country, compliance therewith, the timeline for compliance, the costs associated with compliance and the manufacture of the Inhaler in compliance therewith. The quantities and delivery schedules shall be as specified in Section 7.4 hereof and in purchase orders submitted to AeroGen by PathoGenesis. At PathoGenesis' reasonable request, AeroGen shall provide PathoGenesis with documentation for the purpose of verifying AeroGen's compliance with this section. [*] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.
AutoNDA by SimpleDocs
Manufacturing and Delivery. Below schedule shall be completed by the tenderer and the periods entered shall be binding on the contractor. All periods entered below are to be in weeks and relate to the placing of the contract. Material shall be shipped uniformly throughout the contract. The tenderer shall determine the minimum quantity per each purchase order, and determine the number of times purchase orders can be delivered within two years. And the priority will be given to tenderer who minimize the purchase order quantity and maximize the number of times of purchase orders. Schedule 3 (Manufacturing & Delivery) Required DATA for item (1) Rated 33 KV, 1X400 mm² AL / XLPE / AWA / PVC – Cable. DATA for item (2) Rated 33 KV, 1X500 mm² AL / XLPE / AWA / PVC – Cable. Manufacturer Manufacturing Place Inspection Place Number of purchase order during two years . Manufacturing Period and Delivery (week) to ……………. from purchase order date ………………………………………… ………………………………………… Minimum quantity per each purchase order based on basic price for CU= 9,000 USD/MT AL=2,500 USD/MT Maximum quantity per each purchase order based on basic price for CU= 9,000 USD/MT AL=2,500 USD/MT PRICE ADJUSTMENT FORMULA LME PRICE ADJUSTMENT FORMULA: Final Price = Po + [(CLME(AL) at awarding dated – BLME(AL) quoted price) x V.F(AL)] +[(CLME(CU) at awarding dated – BLME(CU) quoted price) x V.F(CU)] Where:
Manufacturing and Delivery. Subject to the terms and conditions of this Agreement, and at Supernus’ request in accordance with the terms hereof, Supplier shall Manufacture at the Facilities in accordance with the Specifications and in compliance with the Regulatory Scheme, including cGMP, and deliver (pursuant to Section 4.5) Product to Supernus. Subject to Supernus’ prior approval which shall not be unreasonably withheld, Supplier shall have the right to cause any of its Affiliates to perform any of its packaging and quality control obligations hereunder, and Supernus shall accept such performance as if it were performance by Supplier. Supplier shall use its commercially reasonable efforts to meet Supernus’ demand for Product ordered in accordance with the terms hereof.
Manufacturing and Delivery 

Related to Manufacturing and Delivery

  • Manufacturing and Supply Genentech shall be responsible for manufacturing and supplying Licensed Products for clinical use and commercial sale in the Genentech Field.

  • Manufacturing Agreement Each of the Sellers (as applicable) shall have executed and delivered to the Buyer the Manufacturing Agreement with respect to the portion of the Business conducted at the applicable Facility.

  • Manufacturing Services Jabil will manufacture the Product in accordance with the Specifications and any applicable Build Schedules. Jabil will reply to each proposed Build Schedule that is submitted in accordance with the terms of this Agreement by notifying Company of its acceptance or rejection within three (3) business days of receipt of any proposed Build Schedule. In the event of Jabil’s rejection of a proposed Build Schedule, Jabil’s notice of rejection will specify the basis for such rejection. When requested by Company, and subject to appropriate fee and cost adjustments, Jabil will provide Additional Services for existing or future Product manufactured by Jabil. Company shall be solely responsible for the sufficiency and adequacy of the Specifications [***].

  • Manufacturing and Marketing Rights The Company has not granted rights to manufacture, produce, assemble, license, market, or sell its products to any other person and is not bound by any agreement that affects the Company's exclusive right to develop, manufacture, assemble, distribute, market, or sell its products.

  • Manufacturing Technology Transfer With respect to each Technology Transfer Product, upon AbbVie’s written request after the Inclusion Date for the Included Target to which such Technology Transfer Product is Directed, Morphic shall effect a full transfer to AbbVie or its designee (which designee may be an Affiliate or a Third Party manufacturer) of all Morphic Know-How and Joint Know-How relating to the then-current process for the Manufacture of such Technology Transfer Product (the “Manufacturing Process”) and to implement the Manufacturing Process at facilities designated by AbbVie (such transfer and implementation, as more fully described in this Section 5.3, the “Manufacturing Technology Transfer”). To assist with the Manufacturing Technology Transfer, Morphic will make its personnel reasonably available to AbbVie during normal business hours for up to [***] FTE hours with respect to each Included Target (in each case, free of charge to AbbVie) to transfer and implement the Manufacturing Process under this Section 5.3. Thereafter, if requested by AbbVie, Morphic shall continue to perform such obligations; provided, that AbbVie will reimburse Morphic for its full-time equivalent (FTE) costs (for clarity, in excess of [***] FTE hours) and any reasonable and verifiable out-of-pocket costs incurred in providing such assistance. CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.

  • Quality Agreement Concurrently with execution of this Agreement, the Parties will enter into an agreement that details the quality assurance obligations of each Party with respect to the Manufacture and supply of Supplied Products under this Agreement (the “Quality Agreement”). Each Party shall perform its obligations under the Quality Agreement in accordance with the terms and conditions thereof. In the event of a conflict between the terms of the Quality Agreement and the terms of this Agreement, the provisions of the Quality Agreement shall govern.

  • Supply Agreement The Supply Agreement shall have been executed on behalf of the Seller and delivered to the Purchaser.

  • Packaging and Labeling Seller shall properly xxxx, xxxx, and ship Goods and provide Buyer with shipment documentation showing the Order number, Seller’s identification number for the subject Goods, the quantity of goods in shipment and the number of cartons or containers in the shipment.

  • Development Services During the term of this Agreement, the Provider agrees to provide to or on behalf of the Port the professional services and related items described in Exhibit A (collectively, the “Development Services”) in accordance with the terms and conditions of this Agreement. The Provider specifically agrees to include at least one Port representative in any economic development negotiations or discussions in which the Provider is involved concerning (i) a port-related business prospect or (ii) a business transaction which will ultimately require Port involvement, financial or otherwise.

  • Manufacturing (a) The Supplier shall without limitation be responsible, at no additional cost to the Purchaser, for: sourcing and procuring all raw materials for the Products; obtaining all necessary approvals, permits and licenses for the manufacturing of the Products; providing sufficient qualified staff and workers to perform the obligations under this Purchase Agreement; implementing and maintaining effective inventory and production control procedures with respect to the Products; and handling other matters as reasonably requested by the Purchaser from time to time.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!